New drugs that target "zombie" tuberculosis (TB) cells are now a step closer, thanks to a new study led by the University of ...

In a recent study, Associate Professor Makoto Ikeya (Department of Clinical Application) and his team of researchers ...

Depemokimab significantly reduces asthma exacerbations, benefiting patients regardless of their baseline asthma control levels. A biologics license application for depemokimab is currently being ...

Alzheimer's disease (AD) is a common, debilitating neurodegenerative disease affecting about 10% of people over the age of 65 ...

A war weapon used in World War One went on to become a key component in treating blood cancer with chemotherapy ...

A delay, as opposed to a firm stagnation, then, but one unfolding over several years. This applies not only to SMEs, but to big pharma, too, in terms of restructuring and refocusing – even in terms of ...

Alzheimer's disease (AD) is a common, debilitating neurodegenerative disease affecting about 10 percent of people over the ...

Explore how the ratio of pd-1+ treg to ctl and the presence of tertiary lymphoid structures can influence treatment outcomes ...

A similarly gloomy simulation posted by Dr Paulien Moyaert back in May documented how being diagnosed with cancer can lead to ...

Biosimilar SB12 demonstrated comparable efficacy and safety for paroxysmal nocturnal hemoglobinuria (PNH) to its reference drug, showing similar outcomes across diverse patient groups.

After trying to conceive for 18 years, one couple is now pregnant with their first child thanks to the power of artificial ...

New drugs that target ‘zombie’ tuberculosis (TB) cells are now a step closer, thanks to a new study led by the University of Surrey, published in Scientific Reports .